• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US UNK CEMENT GENTAMICIN; BONE CEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US UNK CEMENT GENTAMICIN; BONE CEMENT Back to Search Results
Catalog Number UNK CEMENT GENTAMICIN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Blister (4537)
Event Date 10/15/2021
Event Type  Injury  
Manufacturer Narrative
(b)(4).Trade name gentamicin sulphate, active ingredient(s) gentamicin sulphate, dosage form - powder, strength 1.0g active in our cements.Investigation summary: no device associated with this report was received for examination.A worldwide lot specific complaint database search, or manufacturing record evaluation, was not possible as the required lot number was not provided.The information received will be retained for trend analysis, post market surveillance, or other events within the quality system.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
Patient was revised due to loosening of the tibial and femoral sleeves at the bone to implant interface.It was reported that patient came in with what appeared to be blisters on his thigh.Cultures were negative but surgeon felt as though infection was likely.A superficial exposure was performed finding 2 tracts leading down to the implant through the muscle and capsule.All components were removed.After a thorough i&d was performed, a spacer was fashioned using lps components.This was coated with high dose antibiotic cement and antibiotic beads were placed.Neither of the components were ingrown further pointing to the fact that the patient was still infected.These implants were put in on separate dates, the first section was placed on (b)(6) 2021, while the second group was placed on (b)(6) 2020.The femoral side was revised on (b)(6) 2021 but the tibial components were left in place as they appeared.Doi: (b)(6) 2021 (femoral components & tibial insert), (b)(6) 2020 (tibial tray), unknown (tibial sleeve & tibial stem), dor: (b)(6) 2021, right knee.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK CEMENT GENTAMICIN
Type of Device
BONE CEMENT
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
Manufacturer (Section G)
DEPUY ORTHOPAEDICS, INC. 1818910
700 orthopaedic dr.
warsaw IN 46581 0988
Manufacturer Contact
kara ditty-bovard
700 orthopaedic dr.
warsaw, IN 46581-0988
6107428552
MDR Report Key12846715
MDR Text Key281074907
Report Number1818910-2021-25515
Device Sequence Number1
Product Code MBB
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/19/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK CEMENT GENTAMICIN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/01/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ATT REV SLV LPS FEM ADP +5; ATTUNE REV LPS INSRT XXSM 12MM; ATUN FEM SLV M/L 30MM FULL POR; ATUN TIB SLV M/L 37MM FULL POR; ATUNE PRESSFIT STR STEM18X60MM; ATUNE PRESSFIT STR STEM18X60MM; ATUNE REV RP TIB BASE SZ 3 CEM; CONTROL CABLE W/CABLE SLEEVE; LPS DISTAL FEM COMP XXSM RT; LPS SEGMENTAL COMPONENT 125MM; LPS SEGMENTAL COMPONENT 45MM; UNK CEMENT GENTAMICIN
Patient Outcome(s) Required Intervention;
Patient Age60 YR
Patient SexMale
Patient Weight93 KG
-
-